341 related articles for article (PubMed ID: 27704554)
1. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mahmood I; Ahmad T; Mansoor N; Sharib SM
J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
Mahmood I
J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
Mahmood I
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
Mahmood I; Tegenge MA
J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
[TBL] [Abstract][Full Text] [Related]
6. Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.
Mahmood I
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):53-9. PubMed ID: 24519316
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug clearance in children.
Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of sigmoidal maturation and allometric models: prediction of propofol clearance in neonates and infants.
Mahmood I
Am J Ther; 2013 Jan; 20(1):21-8. PubMed ID: 23299229
[TBL] [Abstract][Full Text] [Related]
9. Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants.
Tegenge MA; Mahmood I; Jiang Z; Forshee R
J Clin Pharmacol; 2018 Jul; 58(7):877-884. PubMed ID: 29489016
[TBL] [Abstract][Full Text] [Related]
10. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.
Mahmood I; Tegenge MA
Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936
[TBL] [Abstract][Full Text] [Related]
12. A comparison of simple allometric and maturation models for the prediction of morphine clearance in pediatrics.
Mahmood I
Drug Metabol Drug Interact; 2011; 26(2):71-7. PubMed ID: 21417797
[TBL] [Abstract][Full Text] [Related]
13. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
Björkman S
Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug clearance in children: an evaluation of the predictive performance of several models.
Mahmood I; Staschen CM; Goteti K
AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
Mahmood I
Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
[TBL] [Abstract][Full Text] [Related]
16. Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
Calvier EA; Krekels EH; Välitalo PA; Rostami-Hodjegan A; Tibboel D; Danhof M; Knibbe CA
Clin Pharmacokinet; 2017 Mar; 56(3):273-285. PubMed ID: 27510367
[TBL] [Abstract][Full Text] [Related]
17. Allometry Is a Reasonable Choice in Pediatric Drug Development.
Liu T; Ghafoori P; Gobburu JV
J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
[TBL] [Abstract][Full Text] [Related]
18. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
Edginton AN; Shah B; Sevestre M; Momper JD
Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
[TBL] [Abstract][Full Text] [Related]
19. The use of PBPK modeling across the pediatric age range using propofol as a case.
Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.
Johnson TN; Rostami-Hodjegan A; Tucker GT
Clin Pharmacokinet; 2006; 45(9):931-56. PubMed ID: 16928154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
